ZIOPHARM Oncology EV to EBIT (TTM)
ZIOPHARM Oncology EV to EBIT (TTM) Chart
ZIOPHARM Oncology Historical EV to EBIT (TTM) Data
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / EBIT
Enterprise value of a company divided by its Earnings Before Interest Taxes (TTM).
EV/EBIT answers the question "What is a company being valued per each dollar of EBIT?" A high (low) EV/EBIT mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/EBITDA : How much is each dollar of EBITDA worth to investors?
EV/Revenues : Or each dollar of Revenues?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
ZIOP EV to EBIT (TTM) Benchmarks
ZIOP EV to EBIT (TTM) Excel Add-In Codes
- Metric Code: ev_ebit
- Latest data point: =YCP("ZIOP", "ev_ebit")
- Last 5 data points: =YCS("ZIOP", "ev_ebit", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Yahoo 03/22 15:42 ET
Yahoo 03/20 11:23 ET
Yahoo 03/20 08:30 ET
Yahoo 03/12 14:40 ET
PR Newswire 03/01 17:10 ET
PR Newswire 02/28 07:10 ET
SA Breaking News 02/24 13:13 ET
Yahoo 02/22 13:04 ET